Register to chat with like-minded investors on our interactive forums.

Get Started

VRTX Vertex Pharmaceuticals Inc

395.8138

-1.55 (-0.39%)

Last Updated: 11:54:40

Delayed by 15 minutes

EC approves Vertex's Kaftrio + ivacaftor for cystic fibrosis in children aged 6 to 11 years

To read the full story on Seeking Alpha, click here.

Vertex Pharmaceuticals (NASDAQ:VRTX)
Historical Stock Chart
From Mar 2024 to Apr 2024

Click Here for more Vertex Pharmaceuticals Charts.

Vertex Pharmaceuticals (NASDAQ:VRTX)
Historical Stock Chart
From Apr 2023 to Apr 2024

Click Here for more Vertex Pharmaceuticals Charts.

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Share on Facebook Share on Twitter Share on Email

Loading Messages....

See More Message Board Posts

Vertex Pharmaceuticals Inc News

More Vertex Pharmaceuticals Inc News Articles

International Star (PK)

Apple Rush (PK)

Net Savings Link (PK)

Global Developments (PK)

Movement Industries (PK)

Rennova Health (PK)

TheGlobe com (PK)

Mike The Pike Productions (PK)

Delayed Upgrade Clock